Browse > Article

Effects of HIF-1α/VP16 Hybrid Transcription Factor on Estrogen Receptor in MCF-7 Human Breast Cancer Cells  

Cho, Jung-Yoon (College of Life Science, Institute of Biotechnology, Department of Bioscience and Biotechnology, Sejong University)
Park, Mi-Kyung (College of Life Science, Institute of Biotechnology, Department of Bioscience and Biotechnology, Sejong University)
Lee, Young-Joo (College of Life Science, Institute of Biotechnology, Department of Bioscience and Biotechnology, Sejong University)
Publication Information
Biomolecules & Therapeutics / v.13, no.4, 2005 , pp. 227-231 More about this Journal
Abstract
The estrogen receptor (ER) is activated and degraded by estrogen. We have examined ER downregulation and activation under hypoxia mimetic conditions. Cobalt chloride induced ER downregulation at 24 h of treatment. This degradation involved hypoxia-inducible factor-1$\alpha$ (HIF-1$\alpha$) as examined by using a constitutively active form of HIF-1$\alpha$, HIF-1$\alpha$/VP16, constructed by replacing the transactivation domain of HIF-1$\alpha$ with that of VP16. Western blot analysis revealed that E2-induced ER downregulation was observed within ${\~}6h$, whereas HIF-1$\alpha$/VP16-induced ER degradation was observed within 12${\~}$20h. HIF-1$\alpha$/VP16 activated the transcription of estrogen-responsive reporter gene in the absence of estrogen. These results suggest that ER downregulation and activation under hypoxia maybe mediated in part by a HIP-1$\alpha$ expression.
Keywords
estrogen receptor; downregulation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Fan, M., Bigsby, R. M., and Nephew, K. P. (2003). The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells. Mol. Endocrinol. 17,356-365   DOI   ScienceOn
2 Hur, E., Chang, K. Y., Lee, E., Lee, S. K. and Park, H. (2001). Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-lalpha. Mol. Pharmacal. 59, 1216-1224   DOI
3 Mazure, N. M., Chauvet, C., Bois-Joyeux, B., Bernard, M. A., Nacer-Cherif, H. and Danan, J. L. (2002). Repression of alphafetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc. Cancer Res. 62, 1158-1165
4 McDonnell, D. P. and Norris, J. D. (2002). Connections and regulation of the human estrogen receptor. Science 296, 1642-1644
5 Nawaz, Z., Lonard, D. M., Dennis, A. P., Smith, C. L. and O'Malley, B. W. (1999). Proteasorne-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. USA 96, 18581862
6 Nawaz, Z. and O'Malley, B. W. (2004). Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription Mol. Endocrinol. 18, 493-499
7 Reid, G., Denger, S., Kos, M. and Gannon, F. (2002) Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. Cell Mol. Life Sci. 59, 821-831   DOI   ScienceOn
8 Shao, W. and Brown, M. (2004). Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy. Breast Cancer Res. 6, 39-52   DOI   ScienceOn
9 Semenza, G. L., Agani, F. Iyer, N. Jiang, B. H., Leung, S., Wiener, C. and Yu, A. (1998). Hypoxia-inducible factor 1: from molecular biology to cardiopulmonary physiology; Chest 114, 40S-45S   DOI   ScienceOn
10 Stoner, M., Saville, B., Wormke, M., Dean, D., Burghardt, R., and Safe, S. (2002). Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells. Mol. Endocrinol. 16,2231-2242   DOI   ScienceOn
11 Wormke, M., Stoner, M., Saville, B., Walker, K., Abdelrahim, M., Burghardt, R. and Safe, S. (2003). The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes. Mol. Cell Bioi. 23, 1843-1855   DOI   ScienceOn
12 Yan, S. F., Zou, Y S., Gao, Y, Zhai, c, Mackman, N., Lee, S. L., Milbrandt, J, Pinsky, D., Kisiel, W. and Stem, D. (1998). Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc. Natl. Acad. Sci. USA 95, 8298-8303
13 Cassoni, P., Catalano, M. G, Sapino, A., Marrocco, T., Fazzari, A., Bussolati, G and Fortunati, N. Oxytocin modulates estrogen receptor alpha expression and function in MCF7 human breast cancer cells. Int. J. Oncol. 21, 375-378 (2002)
14 Beato, M. and Klug, J. (2000). Steroid hormone receptors: an update. Hum. Reprod. Update. 6, 225-236   DOI   ScienceOn
15 Brahimi-Hom, C., Berra, E. and Pouyssegur, J. (2001). Hypoxia: the tumor's gateway to progression along the angiogenic pathway. Trends Cell Biol. 11, S32-36   DOI
16 Gehm, B. D., McAndrews, J. M., Chien, P. Y., and Jameson, J., Resveratrol, L. (1997). A polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 94,14138-14143
17 Vincent, K. A., Shyu, K. G, Luo, Y, Magner, M., Tio, R. A., Jiang, C; Goldberg, M. A., Akita, G. Y, Gregory, R. J, and Isner, J. M. (2000). Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-Ialpha/ VP16 hybrid transcription factor. Circulation 102, 2255-2261   DOI   ScienceOn
18 Alarid, E. T., Bakopoulos, N. and Solodin, N. (1999). Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol. Endocrinol., 13, 1522-1534   DOI   ScienceOn
19 Alarid, E. T., Preisler-Mashek, M. T. and Solodin, N. M. (2003). Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-alpha protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary. Endoerinol. 144, 3469-347   DOI   ScienceOn
20 Belanger, A. J., Lu, H., Date, T., Liu, L. X., Vincent, K. A., Akita, G Y., Cheng, S. H., Gregory, R. J., and Jiang, C. Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor lalpha. J. Mol. Cell Cardiol., 34, 765-774 (2002)   DOI   ScienceOn
21 Catherino, W. H., Wolf, D. M., and Jordan, V. C. (1995). A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog. Mol. Endocrinol., 9 1053-1063   DOI
22 Cicatiello, L. Addeo, R. Altucci, L. Belsito, V. Petrizzi, V. Boccia, M. Cancemi, D. Germano, C. Pacilio, S. Salzano, F. Bresciani, A. Weisz, L. Cicatiello, R. Addeo, L. Altucci, Belsito, Petrizzi, V. Boccia, V. Cancemi, M., Germano, D., Pacilio, C; Salzano, S., Bresciani, F, and Weisz, A. (2000). The antiestrogen ICI 182,780 inhibits proliferation of human breast cancer cells by interfering with multiple, sequential estrogenregulated processes required for cell cycle completion. Mol. Cell Endoerinol. 165, 199-209   DOI   ScienceOn
23 Khissiin, A., EI and Leclercq, G (1999). Implication of protea- some in estrogen receptor degradation. FEBS Lett. 448, 160-166   DOI   ScienceOn